Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 16 ... "Metformin treatment, now widely prescribed in polycystic ovary syndrome, is aimed at correcting the associated insulin resistance, but it has also been shown to ...
2009 NOV 24 ... glucose (RPG) 5.5-11.0 mmol/L (19%). Other indications for OGTT identified included polycystic ovary syndrome or metabolic syndrome (8%), peripheral neuropathy (3%) and as part of a research ...
2009 NOV 2 ... with insulin resistance independently of body mass index and age in women with polycystic ovary syndrome,' have been published. "The aim of this study was to evaluate the association between ...
2009 NOV 16 ... "There is an association between nonalcoholic fatty liver disease (NAFLD) and the polycystic ovary syndrome (PCOS). Marine-derived omega-3 fatty acids have favorable effects on cardiovascular risk ...
2009 NOV 16 ... of Medicine in Philadelphia. "It is now largely accepted that premenopausal women with polycystic ovary syndrome, a condition in which androgens are elevated, have increased health risks. However, the ...
2009 NOV 23 ... "Insulin resistance and hyperinsulinemia play important roles in the pathogenesis of polycystic ovary syndrome (PCOS). In addition, some women with PCOS have been shown to have insulin secretory ...
2009 NOV 1 ... pathway. Previous studies demonstrated the accentuation of the enzyme in patients with polycystic ovary syndrome (PCOS) was the most important mechanism of androgen excess." "We chose ...
2009 NOV 9 ... hirsutism over a 3-month period. In a prospective setting, 27 hirsute women (20 with polycystic ovary syndrome and seven with idiopathic hirsutism) with a mean age of 23.0 +/-5.1 years were studied ...
2009 NOV 2 ... According to recent research from Turkey, "Polycystic ovary syndrome (PCOS) is one of the most common endocrinopathies. Chronic infections may increase the ...
2009 NOV 23 ... female rat offspring. These characteristics overtly resemble the clinical profile of polycystic ovarian syndrome (PCOS) and recent studies have shown that thiazolidinediones such as ... with rosiglitazone treatment. Rosiglitazone reversed some of the nicotine effects in the ovary and increased ovarian vascularization, follicle maturation and improved oocyte ...
2009 NOV 2 ... parameters. Little information is available regarding this relationship in women with polycystic ovary syndrome," scientists in Erlangen, Germany report. "However all those pathologies ...
2009 NOV 1 ... (MCP-1) and macrophage inflammatory protein-1alpha are increased in patients with polycystic ovary syndrome (PCOS) and associated with adiposity, but unaffected by pioglitazone treatment,' are ...
2009 NOV 16 ... the polymorphism of the PPAR-gamma has been studied in type II diabetes mellitus, polycystic ovary syndrome, and insulin resistance syndrome. It is aimed to evaluate the association between ...
2009 NOV 23 ... According to a study from Olivos, Chile, "Polycystic ovary syndrome (PCOS) is characterized by the presence of hyperandrogenism and an increased follicular ...
2009 NOV 23 ... People's Republic of China conducted a study "To analyse the phenotypic spectrum of polycystic ovary syndrome (PCOS) and determine the association between metabolic, hormonal and new ...
2009 NOV 16 ... "The prenatal antecedents of polycystic ovary syndrome (PCOS) are not known, but prenatal androgen exposure is thought to contribute. This has ...
2009 NOV 9 ... from the United States, "To determine whether metformin, when given to women with polycystic ovary syndrome (PCOS), promotes folliculogenesis by prompting a drop in free sex steroids resulting in ...
2009 NOV 2 ... detail in 'The value of measuring anti-Mullerian hormone in women with anovulatory polycystic ovary syndrome undergoing laparoscopic ovarian diathermy,' new data in polycystic ovarian syndrome. ...
